Effects of probenecid on furosemide kinetics and natriuresis in man
- PMID: 902452
- DOI: 10.1002/cpt1977224395
Effects of probenecid on furosemide kinetics and natriuresis in man
Abstract
Furosemide kinetics were studied in 4 normal subjects after single intravenous injections (1 mg/kg). One experiment was done after pretreatment with probenecid. The apparent volume of furosemide distribution was unchanged after probenecid (10.9 L). The mean plasma clearance fell from 155 to 85 ml/min and the mean plasma t1/2 rose from 36 to 61 min. Renal clearance of furosemide fell below 50% of control after probenecid, but the kidney remained the main route of its excretion (75% of the dose appeared in the urine). In another experiment in 4 subjects an infusion of furosemide was sustained following a loading dose to maintain a constant plasma level. After a control period, probenecid was given orally. This resulted in a decrease in renal excretion of furosemide with a simultaneous rise in its plasma concentration. Despite the rising plasma furosemide concentration, however, there was a diminution in both urine flow and the excreted fraction of filtered sodium, which suggested some reduction of diuretic action. In doses commonly used, probenecid reduces renal elimination of furosemide in man with only a mild impairment of its diuretic activity. This suggests that furosemide is eliminated predominantly by way of proximal tubular secretion and that tubular rather than plasma concentration is the main determinant of its diuretic effect.
Similar articles
-
Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.Clin Pharmacol Ther. 1977 Oct;22(4):402-9. doi: 10.1002/cpt1977224402. Clin Pharmacol Ther. 1977. PMID: 902453
-
Preliminary evaluation of furosemide-probenecid interaction in humans.J Pharm Sci. 1980 May;69(5):571-5. doi: 10.1002/jps.2600690526. J Pharm Sci. 1980. PMID: 7381747
-
Diuretic and non-diuretic actions of furosemide: effects of probenecid.Clin Invest Med. 1992 Feb;15(1):82-7. Clin Invest Med. 1992. PMID: 1572111 Clinical Trial.
-
Clinical pharmacokinetics of frusemide.Clin Pharmacokinet. 1979 Jul-Aug;4(4):279-96. doi: 10.2165/00003088-197904040-00002. Clin Pharmacokinet. 1979. PMID: 385209 Review. No abstract available.
-
Drug interactions at excretory mechanisms.Pharmacol Ther. 1981;15(1):69-78. doi: 10.1016/0163-7258(81)90016-4. Pharmacol Ther. 1981. PMID: 7038715 Review. No abstract available.
Cited by
-
Diuretics. Clinical pharmacology and therapeutic use (Part I).Drugs. 1985 Jan;29(1):57-87. doi: 10.2165/00003495-198529010-00003. Drugs. 1985. PMID: 3882391 Review.
-
Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.J Pharmacokinet Biopharm. 1989 Feb;17(1):1-46. doi: 10.1007/BF01059086. J Pharmacokinet Biopharm. 1989. PMID: 2654356 Review.
-
Pharmacokinetics/pharmacodynamics of furosemide in man: a review.J Pharmacokinet Biopharm. 1979 Feb;7(1):1-27. doi: 10.1007/BF01059438. J Pharmacokinet Biopharm. 1979. PMID: 458552
-
The influence of co-administered organic acids on the kinetics and dynamics of frusemide.Br J Clin Pharmacol. 1991 Oct;32(4):489-93. doi: 10.1111/j.1365-2125.1991.tb03936.x. Br J Clin Pharmacol. 1991. PMID: 1958444 Free PMC article.
-
Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.J Pharmacokinet Biopharm. 1983 Dec;11(6):623-40. doi: 10.1007/BF01059061. J Pharmacokinet Biopharm. 1983. PMID: 6678312